Tag Archives: healthcare

Our Health Care Ecosystem

Meekers

There are currently 907 drugs and vaccines targeting more than 100 diseases in development by U.S. biopharmaceutical companies. It is the first step on a path toward bringing much needed treatments to patients. However, with the current focus on the cost of health care, regulatory approval is not the final hurdle. Increasingly, the ability of patients to access new therapies is determined by those who pay for the treatments. Skyrocketing development costs, concerns about the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Approving Drugs for Alzheimer’s Disease

Russ Katz

BIOtechNOW delves into the current state of Alzheimer’s disease research with today’s feature on regulatory challenges. Tomorrow, we cover the first Alzheimer’s prevention trial, and on Wednesday, we will explore the societal and economic impact of this devastating disease. The therapies currently approved for Alzheimer’s disease work by treating the patients’ symptoms, improving their cognitive and overall functions. Increasingly, however, experts are intent on slowing or halting the disease process—before it has ravaged patients’ brains. In February, the U.S. Food Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Patients are the Missing Link in R&D

Elias Zerhouni

An architect does not wait until construction begins to show clients a blueprint. Neither does a caterer prepare a banquet meal without consulting first with the host. In biopharmaceutical science, however, for too long we have developed medicines without engaging patients early on and throughout the process. If scientific innovation is to truly be innovative, we need to be more interested in the people our products will help. We need to rethink innovation. The model we’ve used in healthcare Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Cranial Connections: Ontario’s Brain Research is Hardwired for Success

Moridi

Ontario has long been a leader in life sciences research and technology with brain exploration now taking centre-stage. Most recently, the provincial government committed $100 million to the Ontario Brain Institute, (OBI).  An independent nonprofit formed in 2010, the OBI  will help researchers and business leaders develop new treatments for neurological conditions ranging from Alzheimer’s and Parkinson’s to intractable epilepsy, cerebral palsy, autism and attention deficit and hyperactivity disorder. Headquartered in Toronto – a region that Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Psoriasis Patients Flock to Social Media for Practical Info

Infographic

About eight in 10 psoriasis patients who use health care social networks say they do so primarily to learn how others manage their disease, and get practical tips and advice they couldn’t find elsewhere, according to a survey conducted by the National Psoriasis Foundation, Manhattan Research and Inspire, a company that builds and manages online patient communities. The millions of people with psoriasis, including the one million visitors to TalkPsoriasis in 2012, are not alone Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,